Shanghai RAAS Blood Products Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000C31
CNY
5.68
0.12 (2.16%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
1,509.49
1,257.13
2,138.86
1,946.35
2,005.84
1,862.05
2,062.07
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
1,509.49
1,257.13
2,138.86
1,946.35
2,005.84
1,862.05
2,062.07
Raw Material Cost
942.79
796.21
1,392.45
1,244.28
1,240.64
1,111.82
1,235.95
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
20.81
20.78
17.35
5.75
0.23
0.16
0.02
Selling and Distribution Expenses
183.70
207.74
229.03
171.84
162.20
312.85
172.63
Other Expenses
2.36
5.12
2.91
6.09
3.12
5.85
8.33
Total Expenditure (Excl Depreciation)
1,170.91
1,075.88
1,667.93
1,482.73
1,434.31
1,483.33
1,491.87
Operating Profit (PBDIT) excl Other Income
338.6
181.20000000000002
470.90000000000003
463.6
571.5
378.7
570.2
Other Income
7.23
56.07
23.65
5.74
22.16
14.57
36.57
Operating Profit (PBDIT)
330.93
281.60
526.49
491.58
632.10
432.98
643.51
Interest
20.81
20.78
17.35
5.75
0.23
0.16
0.02
Exceptional Items
0.00
-94.02
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
566.70
460.91
746.42
702.06
765.20
750.23
826.12
Depreciation
0.00
68.56
68.56
51.92
51.92
49.97
49.97
Profit Before Tax
310.11
98.25
440.58
433.90
579.95
382.85
593.52
Tax
60.12
75.53
73.31
76.02
104.08
101.16
96.65
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
315.83
106.27
440.85
463.81
566.08
355.49
597.01
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
315.83
106.27
440.85
463.81
566.08
355.49
597.01
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
-0.18
-0.38
0.14
-0.21
0.44
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
315.83
106.27
440.66
463.43
566.22
355.28
597.45
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
32,524.17
32,456.03
32,583.61
32,408.94
32,499.95
31,926.26
31,159.78
Earnings per share (EPS)
0.05
0.02
0.07
0.07
0.09
0.05
0.09
Diluted Earnings per share
0.05
0.02
0.07
0.07
0.09
0.05
0.09
Operating Profit Margin (Excl OI)
21.44%
12.49%
20.3%
22.29%
27.82%
19.79%
27.01%
Gross Profit Margin
20.54%
13.27%
23.8%
24.96%
31.5%
23.24%
31.21%
PAT Margin
20.92%
8.45%
20.61%
23.83%
28.22%
19.09%
28.95%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Mar 2026 is 20.08% vs -41.23% in Dec 2025

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Mar 2026 is 197.08% vs -75.88% in Dec 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Mar 2026 is 43.55% vs -55.15% in Dec 2025

stock-summary

Interest

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 19.54% in Dec 2025

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

Compare Quarterly Results Of Shanghai RAAS Blood Products Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
1,509.49
0
1,509.49
Other Operating Income
0.00
0.00
0.00
Total Operating income
1,509.49
0
1,509.49
Raw Material Cost
942.79
0
942.79
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
20.81
0
20.81
Selling and Distribution Expenses
183.70
0
183.70
Other Expenses
2.36
0.00
2.36
Total Expenditure (Excl Depreciation)
1,170.91
0
1,170.91
Operating Profit (PBDIT) excl Other Income
338.58
0.00
338.58
Other Income
7.23
0
7.23
Operating Profit (PBDIT)
330.93
0
330.93
Interest
20.81
0
20.81
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
566.70
0
566.70
Depreciation
0.00
0
0.00
Profit Before Tax
310.11
0
310.11
Tax
60.12
0
60.12
Provisions and contingencies
0
0
0.00
Profit After Tax
315.83
0
315.83
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
315.83
0
315.83
Share in Profit of Associates
0
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
315.83
0
315.83
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
32,524.17
0
32,524.17
Earnings per share (EPS)
0.05
0
0.05
Diluted Earnings per share
0.05
0
0.05
Operating Profit Margin (Excl OI)
21.44%
0%
0.00
21.44%
Gross Profit Margin
20.54%
0%
0.00
20.54%
PAT Margin
20.92%
0%
0.00
20.92%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 150.95 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 20.08% vs -41.23% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -24.74% vs -1.86% in Mar 2025

Quarterly - Consolidate Net Profit
Consolidate Net Profit 31.58 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 197.08% vs -75.88% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -44.22% vs -25.21% in Mar 2025

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 32.37 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 43.55% vs -55.15% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is -46.93% vs -5.76% in Mar 2025

Quarterly - Interest
Interest 2.08 Million
in Mar 2026

Figures in Million
stock-summary

QoQ Growth in quarter ended Mar 2026 is 0.00% vs 19.54% in Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 is 10,300.00% vs 0.00% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 21.44%
in Mar 2026

Figures in %
stock-summary

QoQ Growth in quarter ended Mar 2026 has improved from Dec 2025

stock-summary

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025